What is LARC?

LARC must be placed and removed by a trained clinician, which may impact patient autonomy

Contraceptive implant
(about the size of a match stick)

Intrauterine device (IUD)
(about the size of a quarter)

Mechanism of Action:

Prevent fertilization by changing amount and viscosity of cervical mucus, making it impenetrable to sperm

Evidence supports that LNG IUDs do not disrupt pregnancy and are not abortifacients

Most women ovulate normally, but experience diminished menstrual bleeding because of the local effect of levonorgestrel on the endometrium

99.8% effective; the one-year typical use failure rate is 0.2 per 100 women

Mechanism of Action:

Evidence supports that the copper IUD does not disrupt pregnancy and is not an abortifacient

The most common adverse effects reported are abnormal bleeding and pain

99.2% effective; the one-year typical use failure rate is 0.8 per 100 women

Mechanism of Action:

Primary: ovulation suppression
Additional: thickening of cervical mucus and alteration of the endometrial lining

After implant insertion, changes in bleeding patterns are common and include amenorrhea or infrequent, frequent, or prolonged bleeding

Placed subdermally in upper arm; size: 4cm x 2mm (comparable in size to a match stick)

99.9% effective; the one-year typical use failure rate is 0.05 per 100 women

Description	Brand Name of Method	Type of Method	FDA-Approved Duration of Use
Hormonal IUD	Kyleena®	19.5 mg LNG IUD	5 years
	Liletta®	52 mg LNG IUD	6 years
	Mirena®	52 mg LNG IUD	6 years
	Skyla®	13.5 mg LNG IUD	3 years
Copper IUD	Paragard®	Copper IUD	10 years
Contraceptive Implant	Nexplanon®	68 mg ENG implant	3 years